Furthermore, analysis of S100A7 autoantibodies alone or as a composite biomarker to CA125 showed that the sensitivity and specificity remained inferior to CA125 alone at detecting ovarian cancer. This evidence concerns the gene MUC16 and ovarian carcinoma.